¶ ANKRD11 Protein — Ankyrin Repeat Domain 11
[^1]
[^2]
[^3]
[^4]
[^5]
[^6]
[^7]
| ANKRD11 Protein |
|---|
| Protein Name | Ankyrin Repeat Domain 11 |
| Gene | [ANKRD11](/genes/ankrd11) |
| UniProt ID | [Q9UMX0](https://www.uniprot.org/uniprot/Q9UMX0) |
| Molecular Weight | ~256 kDa |
| Subcellular Localization | Nucleus |
| Protein Family | Ankyrin repeat family |
[^8]
[^9]
ANKRD11 (Ankyrin Repeat Domain 11) is a large transcriptional coactivator protein encoded by the ANKRD11 gene located on chromosome 16q24.3 [1]. The protein is characterized by multiple ankyrin repeat domains that mediate protein-protein interactions and function as a histone acetyltransferase (HAT) coactivator [2]. ANKRD11 plays essential roles in regulating gene expression during development, particularly in the nervous system, skeletal growth, and metabolic homeostasis. Heterozygous loss-of-function mutations in ANKRD11 cause KBG syndrome, a neurodevelopmental disorder characterized by intellectual disability, macrodontia, and distinctive facial features [3]. Beyond its role in neurodevelopment, ANKRD11 functions as a tumor suppressor and is implicated in neurodegenerative diseases including Alzheimer's disease and Huntington's disease [4].
ANKRD11 is a large protein with a complex domain architecture:
¶ Domain Organization
- Ankyrin Repeat Domains: Six ankyrin repeats in the central region (ANK1-ANK6)
- N-terminal Region: Contains transcriptional activation domain
- C-terminal Region: Additional regulatory sequences
- Ankyrin Repeat Fold: Consists of tandem repeats of ~33 amino acids forming a螺旋-转角-螺旋 motif
- HAT Domain: Histone acetyltransferase activity in N-terminal region
- Nuclear Localization Signals: Two NLS sequences for nuclear import
- Molecular Weight: ~256 kDa (one of the largest ankyrin repeat proteins)
- Phosphorylation: Multiple serine/threonine phosphorylation sites
- Acetylation: Lysine acetylation regulates protein function
- Ubiquitination: Controls protein stability and turnover
- Sumoylation: Modulates transcriptional activity
ANKRD11 is a potent transcriptional coactivator [5]:
Histone Acetyltransferase Activity:
- Acetylates histone H3 and H4
- Opens chromatin structure
- Enhances transcription factor binding
Protein-Protein Interactions:
- Interacts with p300/CBP histone acetyltransferases
- Binds transcription factors (p53, NF-κB, estrogen receptor)
- Recruits chromatin remodeling complexes
Target Genes:
- Cell cycle regulators (p21, cyclin D1)
- Metabolic genes
- Developmental transcription factors
ANKRD11 is critical for proper brain development [6]:
Neuronal Differentiation:
- Promotes neuronal lineage commitment
- Regulates neurite outgrowth
- Supports synaptic formation
Synaptic Plasticity:
- Controls synaptic protein expression
- Modulates dendritic spine morphology
- Essential for learning and memory
The protein influences systemic growth:
Skeletal Growth:
- Regulates chondrocyte proliferation
- Controls bone development
- Influences growth plate function
Metabolic Homeostasis:
- Modulates insulin signaling
- Regulates lipid metabolism
- Controls energy expenditure
Heterozygous ANKRD11 mutations cause KBG syndrome [7]:
Clinical Features:
- Intellectual disability (mild to moderate)
- Macrodontia (large upper incisors)
- Distinctive facial features (triangular face, hypertelorism)
- Short stature
- Hand anomalies (brachydactyly)
- Seizures (in some patients)
- Autism spectrum disorder
Genetic Basis:
- Truncating mutations (nonsense, frameshift)
- Missense mutations affecting ankyrin repeats
- Dominant-negative effects
Pathogenesis:
- Haploinsufficiency reduces ANKRD11 function
- Impaired transcriptional activation
- Disrupted neuronal development
ANKRD11 is implicated in AD pathogenesis [8]:
Transcriptional Dysregulation:
- Reduced ANKRD11 expression in AD brain
- Impaired p53 function
- Altered cell cycle regulation
Amyloid-β Effects:
- ANKRD11 downregulation by Aβ
- Enhanced neuronal vulnerability
- Synaptic dysfunction
Therapeutic Potential:
- ANKRD11 upregulation may protect neurons
- Targeting HAT activity
- Restoring transcriptional balance
ANKRD11 dysfunction contributes to HD [9]:
Transcriptional Alterations:
- Mutant huntingtin disrupts ANKRD11 function
- Altered gene expression patterns
- Impaired neuronal survival
Mechanisms:
- Reduced neurotrophic support
- Enhanced excitotoxicity
- Mitochondrial dysfunction
ANKRD11 functions as a tumor suppressor [10]:
Genetic Alterations:
- Somatic mutations in various cancers
- Deletion in 16q24.3 region
- Epigenetic silencing
Tumor Suppressor Functions:
- Cell cycle arrest
- Apoptosis induction
- Inhibition of proliferation
Therapeutic Implications:
- ANKRD11 restoration approaches
- HAT domain as drug target
- Synthetic lethality strategies
ANKRD11 mutations contribute to ASD [11]:
Neurodevelopmental Mechanisms:
- Impaired synaptic function
- Altered social behavior
- Repetitive phenotypes
Molecular Pathways:
- Dysregulated gene expression
- Chromatin remodeling defects
- Synaptic protein dysregulation
| Protein |
Interaction Type |
Functional Significance |
| p300/CBP |
Coactivator |
Histone acetylation, transcription |
| p53 |
Transcription factor |
Cell cycle arrest, apoptosis |
| NF-κB |
Transcription factor |
Inflammation, survival |
| Histone H3/H4 |
Substrate |
Chromatin modification |
| HDAC |
Regulator |
Transcriptional repression |
Targeting ANKRD11 for disease treatment:
- Gene Therapy: Viral vector delivery of functional ANKRD11
- Small Molecule Activators: Compounds that enhance ANKRD11 expression
- HAT Modulators: Targeting histone acetyltransferase activity
- Chromatin Modifiers: Epigenetic approaches to restore function
ANKRD11 as a potential biomarker:
- Expression Levels: Reduced in AD/HD brain
- Mutations: Diagnostic for KBG syndrome
- Therapeutic Response: Marker of treatment efficacy